DGX Cloud
NVIDIA's AI factory in the cloud
Platform · Cloud SaaSCompany source
Company profile
About Nvidia Clara
NVIDIA Clara represents NVIDIA's comprehensive platform for healthcare and life sciences, delivering accelerated computing solutions that power AI innovation across the medical industry. The platform leverages NVIDIA's advanced GPU architectures including Blackwell, Hopper, and Ada Lovelace to enable breakthrough performance in medical imaging analysis, drug discovery, genomics research, and clinical AI applications. Clara provides healthcare organizations with the computational infrastructure needed to develop, deploy, and scale AI models for diagnostic imaging, patient monitoring, treatment planning, and biomedical research. The platform integrates NVIDIA's full stack of AI technologies including CUDA-X libraries, NIM microservices, and enterprise-grade software tools designed specifically for healthcare workflows. NVIDIA Clara supports both cloud-based and on-premises deployments through DGX systems, enabling health systems, research institutions, pharmaceutical companies, and medical device manufacturers to accelerate their AI initiatives. The platform addresses critical healthcare challenges including medical image reconstruction and analysis, protein structure prediction, virtual drug screening, and clinical decision support. With support for federated learning, NVIDIA Clara enables collaborative AI development while maintaining patient privacy and data security. The platform's modular architecture allows healthcare organizations to build custom AI pipelines tailored to their specific clinical and research needs, from radiology and pathology to genomics and real-time patient monitoring at the edge.
Company description Nvidia Clara official website
Primary marketGenerative AI & Healthcare Infrastructure
Commercial modelCommercial information available on request
Work at Nvidia Clara?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Clinical decision support
- Drug discovery
- Genomics
- Medical imaging analysis
- Pathology
- Patient monitoring
- Radiology
Who it serves
- Academic Medical Centers
- Biotechnology Companies
- Health Systems
- Medical Device Manufacturers
- Pharmaceutical Companies
- Research Institutions
Deployment & integration
Api Only · Cloud Saas · Hybrid · On Premise deployment with recorded integration context.
Geographic context
MarketsAsia Pacific · Europe · Global · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launch of Blackwell architecture for AI reasoning, introduction of GB200 NVL72 and GB300 NVL72 systems for scalable AI inference, expansion of DGX Cloud services, development of Vera Rubin platform for agentic AI, introduction of DSX Platform for AI factory optimization
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
DGX Platform
Enterprise AI factory for model development and deployment
Platform · On PremiseCompany source
DSX Platform
Build AI factories optimized for lowest cost tokens per megawatt
Platform · On PremiseCompany source
NVIDIA AI Enterprise
Enterprise AI software suite for data center deployments
Software · HybridCompany source
NVIDIA Base Command Manager
Centralized platform to manage and monitor AI workloads in data centers
Software · On PremiseCompany source
NVIDIA Clara
AI platforms for healthcare and life sciences innovation
Platform · HybridCompany source
NVIDIA Mission Control
Powers AI factory operations from developer workloads to infrastructure
Software · On PremiseCompany source
NVIDIA NIM
AI inference microservices for healthcare applications
Api · Api OnlyCompany source
NVIDIA Omniverse
Industrial AI platform for healthcare simulation and collaboration
Platform · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Nvidia Clara
Recent articles published on Nvidia Clara's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Generative AI & Healthcare Infrastructure
Companies providing generative AI platforms, large language models (LLMs), foundation models, or broad AI infrastructure specifically designed for healthcare applications. These companies serve multiple clinical use cases across the health system rather than focusing on a single clinical application or disease area.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.